[The effect of serum free fatty acid on serum free thyroid hormone fractions in low T3 syndrome]. 1987

T Nomura, and T Sakurada, and K Yoshida, and K Kaise, and N Kaise, and Y Itagaki, and M Yamamoto, and S Saito, and I Hirayama, and M Mizugaki
Second Department of Internal Medicine, Tohoku University School of Medicine, Sendai, Japan.

We studied the role of serum free fatty acid (FFA) in the elevation of serum dializable fraction of T4 (DFT4) and evaluated the serum free T4 (FT4) level in low T3 syndrome. Serum DFT4 and DFT3 were measured by equilibrium dialysis method with phosphate buffer, and serum FFA concentration was obtained by gas chromatography. In patients with nonthyroidal systemic illnesses who showed reduced serum total T3 (TT3) and normal total T4 (TT4) (low T3 group, TT3 48 +/- 14 ng/dl, n = 10), mean (+/- SD) DFT4 value (0.032 +/- 0.05%) was significantly higher than that of the group of systemic illnesses with normal TT3 and TT4 (normal T3 group, TT3 79 +/- 7 ng/dl, n = 10). Mean TT4 value of low T3 group (6.5 +/- 1.0 micrograms/dl) was lower than that of normal T3 group (8.6 +/- 2.4 microgram/dl, p less than 0.02). There was no difference in mean absolute FT4 (AFT4) value between the two groups (2.07 +/- 0.46 vs 2.19 +/- 0.53 ng/dl). On the other hand, there was no significant difference in DFT3 value between the groups (0.274 +/- 0.043 vs 0.247 +/- 0.035%), and mean AFT3 of low T3 group (1.29 +/- 0.39 pg/ml) was low than that of normal T3 group (1.92 +/- 0.26 pg/ml, p less than 0.01). In cases of low and normal T3 groups (n = 20), serum thyroxine binding globulin (TBG) concentration had a negative correlation with DFT3 (r = -0.707, p less than 0.001), but not with DFT4. Although there were no significant differences in serum albumin and TBG concentrations between the two groups, the mean serum total FFA concentration and molar ratio of FFA to albumin in low T3 group (579 +/- 249 microM and 1.31 +/- 0.61) were significantly higher than those in normal T3 group (345 +/- 170 microM and 0.75 +/- 0.32, p less than 0.05 and less than 0.025, respectively). All of FFA concentrations in low T3 group, especially oleate, were higher than those in normal T3 group. Moreover, the higher the total FFA concentration was, the greater was the percent fraction of oleate. DFT4 values were significantly increased by the addition of 1 mM oleate to the sera of low T3 group, and this effect was more marked in the sera of the patients with lower albumin concentration.(ABSTRACT TRUNCATED AT 400 WORDS)

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009829 Oleic Acids A group of fatty acids that contain 18 carbon atoms and a double bond at the omega 9 carbon. Octadecenoic Acids,Acids, Octadecenoic,Acids, Oleic
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D005067 Euthyroid Sick Syndromes Conditions of abnormal THYROID HORMONES release in patients with apparently normal THYROID GLAND during severe systemic illness, physical TRAUMA, and psychiatric disturbances. It can be caused by the loss of endogenous hypothalamic input or by exogenous drug effects. The most common abnormality results in low T3 THYROID HORMONE with progressive decrease in THYROXINE; (T4) and TSH. Elevated T4 with normal T3 may be seen in diseases in which THYROXINE-BINDING GLOBULIN synthesis and release are increased. High T4 Syndrome,Low T3 Syndrome,Low T3 High T4 Syndrome,Low T3 and Low T4 Syndrome,Low T3-High T4 Syndrome,Low T3-Low T4 Syndrome,Non-Thyroidal Illness Syndrome,Sick Euthyroid Syndrome,Euthyroid Sick Syndrome,High T4 Syndromes,Low T3 Low T4 Syndrome,Non Thyroidal Illness Syndrome,Syndrome, Non-Thyroidal Illness,Syndrome, Sick Euthyroid,Syndromes, Non-Thyroidal Illness
D005230 Fatty Acids, Nonesterified FATTY ACIDS found in the plasma that are complexed with SERUM ALBUMIN for transport. These fatty acids are not in glycerol ester form. Fatty Acids, Free,Free Fatty Acid,Free Fatty Acids,NEFA,Acid, Free Fatty,Acids, Free Fatty,Acids, Nonesterified Fatty,Fatty Acid, Free,Nonesterified Fatty Acids
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013963 Thyroid Hormones Natural hormones secreted by the THYROID GLAND, such as THYROXINE, and their synthetic analogs. Thyroid Hormone,Hormone, Thyroid,Hormones, Thyroid
D013975 Thyroxine-Binding Proteins Blood proteins that bind to THYROID HORMONES such as THYROXINE and transport them throughout the circulatory system. Thyroxine Transport Protein,Thyroxine-Binding Protein,Thyroxine Binding Protein,Thyroxine Binding Proteins

Related Publications

T Nomura, and T Sakurada, and K Yoshida, and K Kaise, and N Kaise, and Y Itagaki, and M Yamamoto, and S Saito, and I Hirayama, and M Mizugaki
April 1979, Scandinavian journal of clinical and laboratory investigation,
T Nomura, and T Sakurada, and K Yoshida, and K Kaise, and N Kaise, and Y Itagaki, and M Yamamoto, and S Saito, and I Hirayama, and M Mizugaki
February 1969, Clinica chimica acta; international journal of clinical chemistry,
T Nomura, and T Sakurada, and K Yoshida, and K Kaise, and N Kaise, and Y Itagaki, and M Yamamoto, and S Saito, and I Hirayama, and M Mizugaki
July 1969, Casopis lekaru ceskych,
T Nomura, and T Sakurada, and K Yoshida, and K Kaise, and N Kaise, and Y Itagaki, and M Yamamoto, and S Saito, and I Hirayama, and M Mizugaki
October 1988, The Journal of clinical endocrinology and metabolism,
T Nomura, and T Sakurada, and K Yoshida, and K Kaise, and N Kaise, and Y Itagaki, and M Yamamoto, and S Saito, and I Hirayama, and M Mizugaki
January 1982, Pediatria polska,
T Nomura, and T Sakurada, and K Yoshida, and K Kaise, and N Kaise, and Y Itagaki, and M Yamamoto, and S Saito, and I Hirayama, and M Mizugaki
September 1967, Horumon to rinsho. Clinical endocrinology,
T Nomura, and T Sakurada, and K Yoshida, and K Kaise, and N Kaise, and Y Itagaki, and M Yamamoto, and S Saito, and I Hirayama, and M Mizugaki
January 1964, The American journal of physiology,
T Nomura, and T Sakurada, and K Yoshida, and K Kaise, and N Kaise, and Y Itagaki, and M Yamamoto, and S Saito, and I Hirayama, and M Mizugaki
April 1974, American journal of clinical pathology,
T Nomura, and T Sakurada, and K Yoshida, and K Kaise, and N Kaise, and Y Itagaki, and M Yamamoto, and S Saito, and I Hirayama, and M Mizugaki
April 1981, Klinische Wochenschrift,
T Nomura, and T Sakurada, and K Yoshida, and K Kaise, and N Kaise, and Y Itagaki, and M Yamamoto, and S Saito, and I Hirayama, and M Mizugaki
August 1986, The American journal of physiology,
Copied contents to your clipboard!